VanEck Associates’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $46K | Buy |
|
|||||
|
2025
Q2 | $19K | Hold |
|
|||||
|
2025
Q1 | $14K | Sell |
|
|||||
|
2024
Q4 | $26K | Buy |
|
|||||
|
2024
Q3 | $32K | Sell |
|
|||||
|
2024
Q2 | $49K | Buy |
|
|||||
|
2024
Q1 | $58K | Buy |
|
|||||
|
2023
Q4 | $59K | Buy |
|
|||||
|
2023
Q3 | $51K | Sell |
|
|||||
|
2023
Q2 | $3.45M | Buy |
|
|||||
|
2023
Q1 | $3.12M | Sell |
|
|||||
|
2022
Q4 | $3.27M | Buy |
|
|||||
|
2022
Q3 | $3.53M | Sell |
|
|||||
|
2022
Q2 | $4.4M | Buy |
|
|||||
|
2022
Q1 | $5.68M | Sell |
|
|||||
|
2021
Q4 | $9.45M | Buy |
|
|||||
|
2021
Q3 | $8.97M | Buy |
|